Cardiff and Nerviano Execute Confirmation Agreement
Cardiff Oncology, Inc. has executed an amendment to its license agreement with Nerviano Medical Sciences, effectively resolving ongoing legal disputes. This is a significant development as it formalizes the mutual settlement and clears previous uncertainties regarding the parties' commercial and IP rights under their collaboration.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day